Home/Pipeline/Next-Generation Coagulation Factors

Next-Generation Coagulation Factors

Hemophilia A & B

DevelopmentOptimization

Key Facts

Indication
Hemophilia A & B
Phase
Development
Status
Optimization
Company

About Grifols

Grifols is a century-old global leader in plasma-derived medicines and diagnostics, operating across four core divisions: Biopharma, Diagnostics, Bio Supplies, and Hospital Healthcare Solutions. Its mission to improve health is powered by deep plasma science expertise, a robust manufacturing footprint, and significant industry recognition, including repeated honors from TIME and Forbes. The company's strategy focuses on vertical integration in plasma, geographic expansion, and scientific innovation, including exploring new therapeutic areas like neurology through its CHRONOS-PD platform.

View full company profile